UNCLAIMED
Parexel
Overview
Parexel is a prominent company in the Business Services sector, particularly focused on research and development within the healthcare and pharmaceutical industries. Established in 1983 and headquartered in the United States, Parexel employs over 10,000 individuals and generates significant revenue. The company's published documents reflect its expertise in clinical trials, regulatory affairs, and in vitro diagnostics (IVD). Notably, Parexel addresses the importance of increasing trial participation and ensuring population diversity in drug development, as highlighted in its research articles. Additionally, the company provides insights into the implications of the European Union's In Vitro Diagnostic Regulation (IVDR), emphasizing the critical role of systematic literature reviews and scientific validity reports in compliance and patient safety. Parexel's guides and articles also explore clinical trial methodologies, particularly in Australia, showcasing its commitment to enhancing the efficiency and effectiveness of clinical research. Overall, Parexel's documentation underscores its focus on advancing healthcare solutions through rigorous research and regulatory compliance.